Industries
|
Companies
|
Filings
|
News
|
CaseLaw
|
Annual Reports
|
UK
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Latest F-1/A SEC Filings
Registration statement for certain foreign private issuers:
[Amend]
NYMOX PHARMACEUTICAL CORP, F-1/A, 2000-03-09
FAQ
|
Privacy
|
Terms Of Service
|
Contact
© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission